Understanding Osteoporosis Medications: Biologics & Biosimilars Webinar

Understanding Osteoporosis Medications: Biologics & Biosimilars Webinar

Join BHOF Chief Medical Officer, Andrea Singer, MD and Cate Lockhart, PharmD, PhD, Executive Director of the Biologics and Biosimilars Collective Intelligence Consortium for an informative webinar on Monday, July 8, at 3:00PM ET about osteoporosis medication and treatment options. You will learn about weighing the associated benefits and risks of medications and gain insight into speaking with your healthcare practitioner about treatment planning and osteoporosis management. The differences between biologics and biosimilars will also be discussed.